Life Sciences & MOBs: Persistent Demand Amidst Broader CRE Headwinds
By Majid Radaei, RadCRE · · Market Updates
Despite broader CRE downturns, life sciences and medical office building (MOB) sectors continue to attract robust investment, with over $18 billion in transactions recorded in 2023.
While many commercial real estate sectors grapple with elevated interest rates and tighter lending conditions, the life sciences and medical office building (MOB) segments continue to demonstrate remarkable resilience and robust investor demand. This persistent appeal stems from strong underlying demographic trends, technological advancements, and a relatively inelastic demand for healthcare services.
Life Sciences: Innovation Drives Investment
The life sciences sector, encompassing specialized research & development (R&D) facilities, lab space, and biomanufacturing plants, remains a darling for institutional capital. Despite a significant slowdown from the frenetic pace of 2021-2022, major players like Blackstone and Alexandria Real Estate Equities continue to deploy capital strategically.
According to Cushman & Wakefield's Q4 2023 Life Sciences report, total investment volume for the sector reached approximately $18.5 billion across the U.S. in 2023. While lower than peak years, this figure still represents a substantial commitment from investors. Demand remains particularly strong in established clusters such as Boston-Cambridge, the San Francisco Bay Area, and San Diego. For instance, in Q1 2024, BioMed Realty, a Blackstone portfolio company, announced plans for a new 500,000-square-foot life sciences campus in Allston, Boston, underscoring ongoing development appetite in premier markets.
Vacancy rates, while ticking up slightly from historic lows, remain healthy, often below 10% in core submarkets. Rents continue to see upward pressure for state-of-the-art facilities that meet the stringent requirements of modern biotech and pharmaceutical companies. For example, prime lab space in Cambridge, MA, can still command asking rents upwards of $110 per square foot NNN.
Medical Office Buildings: Essential Services Fuel Stability
Medical Office Buildings (MOBs) are another non-discretionary asset class providing stable, long-term returns. The aging population and the shift towards outpatient care continue to be powerful tailwinds. Investors are attracted to MOBs' high tenancy rates, long lease terms with built-in escalations, and recession-resistant characteristics.
Real Capital Analytics (RCA) data shows that MOB transaction volume remained robust in 2023, exceeding $15 billion. Average cap rates for well-located, amenitized MOBs have seen some outward movement in line with higher interest rates but generally remain tighter than those for traditional office assets, often ranging from 5.75% to 7.00% depending on tenant credit, lease term, and market. For example, Harrison Street Capital, a prominent investor in social infrastructure, recently acquired a portfolio of MOBs across several Sun Belt states, demonstrating continued confidence in the sector's fundamentals.
The fragmented ownership structure of MOBs also presents opportunities for consolidation and value creation. Health systems are increasingly shedding non-core real estate assets, providing a pipeline of acquisition opportunities for specialized public and private REITs and funds.
RadCRE Perspective
"The life sciences and MOB sectors are not just resilient; they are proving to be truly counter-cyclical in the current market environment," notes Majid Radaei, Founder of RAD Commercial Realty. "We are seeing institutional capital continue to chase quality assets in these segments, understanding that the powerful demographic demographic and technological drivers here are long-term. While cap rates have adjusted some, the spread between yield and cost of capital is often more compelling than in other asset classes, particularly when securing competitive financing. For life sciences, it's about identifying the truly cutting-edge submarkets and understanding the specialized needs of tenants. For MOBs, it's about the essential nature of the service and the long-term embedded value. RadCRE is actively helping clients navigate these nuanced markets, advising on optimal capital structures, whether it's through conventional loans or more bespoke financing solutions that fit the unique risk-return profiles of these specialized assets."
RadCRE assists clients in identifying and underwriting high-potential life sciences and medical office investment opportunities. Our expertise spans financing strategies, including bridge loans competitive at SOFR + 300-600 bps, to structuring long-term agency or CMBS debt to optimize deal returns, and connecting buyers with specialized equity partners for these unique asset classes.
Tags: life sciences real estate, medical office building investment, CRE investment trends, RadCRE, commercial real estate financing, capital markets
Sources: Cushman & Wakefield, Real Capital Analytics (RCA), CoStar, Commercial Observer